ClinicalTrials.Veeva
Menu

Find clinical trials for Heart Disease in Taipei City

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Heart Diseases
Cardiovascular Diseases
Heart Failure
Coronary Artery Disease
Myocardial Ischemia
Aortic Valve Stenosis
Heart Valve Diseases

Heart Disease trials near Taipei City, TWN:

Drug-Coated Balloon vs. Drug-Eluting Stent for Clinical Outcomes in Patients With Large Coronary Artery Disease (REVERSE)

the safety and efficacy of drug-coated balloon (DCB) treatment compared to drug-eluting stenting (DES) in patients with large coronary artery disease...

Active, not recruiting
Coronary Artery Disease
Myocardial Ischemia
Device: SeQuent® Please NEO drug-coated balloon catheter
Device: Current-generation drug-eluting stent
B. Braun
B. Braun

New Taipei City, Taiwan and 20 other locations

The purpose of this study is to establish the safety and effectiveness of pulsed field ablation as a first-line ablation treatment for subjects with...

Active, not recruiting
Persistent Atrial Fibrillation
Device: FARAPULSE™ Pulsed Field Ablation (PFA) System
Drug: Anti-Arrhythmic Drug (AAD): Flecainide, Sotalol, Propafenone, Dofetilide, and Dronedarone
Boston Scientific
Boston Scientific

Taipei, Taiwan and 60 other locations

Transthyretin amyloidosis (ATTR) is a disease where the normally occurring transthyretin (TTR) protein falls apart and forms amyloid, a stic...

Enrolling
Heart Diseases
Transthyretin Amyloidosis
Drug: Placebo oral tablet
Drug: Acoramidis

Phase 3

Eidos Therapeutics

Taipei, Taiwan and 103 other locations

Locations recently updated

with placebo in participants with atherosclerotic cardiovascular disease (ASCVD) and/or chronic kidney disease (CKD). Participation...

Enrolling
Chronic Kidney Disease
Atherosclerosis Cardiovascular Disease
Drug: Orforglipron
Drug: Placebo

Phase 3

Lilly
Lilly

Taipei, Taiwan and 561 other locations

This is a Phase 3, prospective, open-label, multicenter study to assess the efficacy of NH002-enhanced echocardiography in subjects with suboptimal e...

Active, not recruiting
Cardiac Diseases
Drug: NH002 (Perflutren Lipid Microspheres) Injectable Suspension

Phase 3

Trust Bio-sonics

Taipei, Taiwan and 5 other locations

Recurrent atypical atrial flutter (AFL) after prior atrial fibrillation or flutter ablation remains challenging to treat, and conventional radiofrequ...

Invitation-only
Atrial Flutter
Atypical Atrial Flutter
Procedure: Point-by-point pulsed-field catheter ablation
Taipei Veterans General Hospital

Taipei, Taiwan

This is a pivotal phase III study designed to evaluate safety, tolerability, and efficacy of inclisiran in children (aged 2 to \<12 years) with homoz...

Enrolling
Familial Hypercholesterolemia - Homozygous
Drug: Placebo
Drug: Inclisiran

Phase 3

Novartis
Novartis

Taipei, Taiwan and 18 other locations

This is a pivotal phase III study designed to evaluate safety, tolerability, and efficacy of inclisiran in children (aged 6 to \<12 years) with heter...

Enrolling
Familial Hypercholesterolemia - Heterozygous
Drug: Placebo
Drug: Inclisiran

Phase 3

Novartis
Novartis

Taipei, Taiwan and 63 other locations

with Pulmonary Hypertension Associated with Interstitial Lung Disease (PH-ILD). It will also learn about the safety of mirivadelgat. The mai...

Enrolling
Group 3 Pulmonary Hypertension
Drug: Mirivadelgat
Drug: placebo

Phase 2

Foresee Pharmaceuticals

Taipei, Taiwan and 10 other locations

aims to assess the improvement in left ventricular function of the heart following the administration of MiSaver, as well as to determine the...

Not yet enrolling
Acute Myocardial Infarction (AMI)
Biological: Cord Blood Nucleated cells

Phase 2

HONYA Medical Co Ltd

Hsinchu, Taiwan and 3 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems